Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide spray vs betamethasone drops vs budesonide nebulization after FESS for sinonasal polyposis
IRCT20201021049095N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Sep 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of budesonide and betamethasone in chronic rhinosinusitis with nasal polyps (CRSwNP) (3 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Visual analog scale, Patient self-satisfaction with surgery results and 6 more. Started Sep 2021; status: completed.
02
Drugs
budesonidebetamethasone
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on IRCT20201021049095N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201021049095N1.